Related Experiment Video
Updated: Mar 10, 2026

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Management of cardiovascular disease in aging persons with haemophilia
Roger E G Schutgens1, Michiel Voskuil, Evelien P Mauser-Bunschoten
1Roger E. G. Schutgens, MD, PhD, MSc, Van Creveldkliniek, UMC Utrecht, Heidelberglaan 100 3584CX Utrecht, The Netherlands, Tel: +31 88 7558450, r.schutgens@umcutrecht.nl.
Insights
Managing cardiovascular disease in aging hemophilia patients presents challenges. This review covers current knowledge on risk factors, prevalence, and anticoagulation strategies for hemophilia complications.
Area of Science:
- Cardiology
- Hematology
Background:
- Aging hemophilia populations face increasing age-related comorbidities.
- Cardiovascular disease (CVD) management in hemophilia patients is complex.
- Prevalence, risk factors, and management of CVD in hemophilia are increasingly understood.
Purpose of the Study:
- To provide an overview of current knowledge on cardiovascular disease in hemophilia.
- To highlight challenges in managing hemophilia patients with CVD.
- To discuss new insights in anticoagulation for hemophilia-related cardiovascular issues.
Main Methods:
- Literature review of current knowledge on CVD in hemophilia.
- Analysis of prevalence and risk factors for CVD in hemophilia.
- Examination of anticoagulation management strategies for atrial fibrillation and coronary ischemia in hemophilia.
Main Results:
- Hypertension and overweight are common risk factors in hemophilia patients.
- New insights into anticoagulation for atrial fibrillation and coronary ischemia have emerged.
- Substantial improvements in understanding CVD in hemophilia have been made.
Conclusions:
- Cardiovascular disease is a significant medical issue in the aging hemophilia population.
- Effective management requires addressing common risk factors like hypertension and overweight.
- Ongoing research provides new strategies for anticoagulation in hemophilia patients with CVD.
Abstract:
With the aging of the haemophilia population, age related comorbidities become more and more a medical issue. Managing haemophilia patients with cardiovascular disease is a difficult task for many haemophilia-treating physicians. Over the years, insights on prevalence, risk factors and management of cardiovascular disease in haemophilia have improved substantially. It is now recognised that many risk factors, such as hypertension and overweight, occur quite frequently in patients with haemophilia. Several new insights in anticoagulation management of atrial fibrillation and coronary ischaemia in haemophilia have been suggested. This review provides an general overview of the current knowledge of these topics in literature.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

